Top compounds associated with response to OR4C13


Feature Type Standardized
Nominal ANOVA
mRNA ATRA GDSC1000 pan-cancer AAC -0.052 0.1
mRNA Docetaxel gCSI pan-cancer AAC -0.078 0.1
mRNA tandutinib CTRPv2 pan-cancer AAC -0.054 0.1
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.056 0.1
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.053 0.1
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.053 0.1
mRNA thapsigargin gCSI pan-cancer AAC -0.08 0.1
mRNA paclitaxel gCSI pan-cancer AAC -0.074 0.1
mRNA Erlotinib gCSI pan-cancer AAC -0.079 0.1
mRNA ouabain CTRPv2 pan-cancer AAC -0.05 0.1
Download CSV